CGTN spoke to Yang Xiaoming, chairman of Sinopharm China National Biotec Group (CNBG), about the significance of the vaccine's approval from WHO, China achieving herd immunity by early 2022, and a new vaccine that is currently under clinical trial. https://news.cgtn.com/news/2021-05-08/Sinopharm-WHO-approval-shows-international-recognition-of-vaccine-105KT928oWk/index.html …pic.twitter.com/ARBWfJA7T3
10:30 AM - 8 May 2021
1 reply
4 retweets
15 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.